Spravato® (esketamine) is an FDA-approved nasal spray specifically indicated for adults with treatment-resistant depression (TRD), which is a condition in which at least two oral
Spravato® (esketamine) differs from traditional antidepressants in both its mechanism of action and speed of symptom relief. Most conventional antidepressants, such as SSRIs and SNRIs,
Depression can be persistent and difficult to treat, especially when traditional approaches like medication and talk therapy do not provide sufficient relief. In recent years,
Severe depression can feel overwhelming, but effective treatment does not always require hospitalization. Outpatient care offers a structured, clinically supported approach that allows individuals to
Ketamine has emerged as a promising treatment for PTSD and anxiety by working through mechanisms distinct from traditional psychiatric medications. But how does ketamine work?
When considering outpatient depression treatment for recovery, it’s essential to assess both the severity of your symptoms and your current level of functioning in daily
As Transcranial Magnetic Stimulation (TMS) becomes a more accepted form of therapy for mental health conditions, many potential patients ask, does insurance cover TMS for
Spravato® (esketamine) has shown significant effectiveness in treating depression, particularly for patients who haven’t responded to traditional antidepressants. Clinical trials have demonstrated that when used
Yes, accelerated Transcranial Magnetic Stimulation (TMS) therapy appears to be effective for depression based on recent research, though it’s still an evolving treatment approach. Research
Spravato®, an esketamine nasal spray, has demonstrated notable success rates in treating treatment-resistant depression. However, outcomes vary depending on the treatment phase and study parameters.
